bioAffinity Technologies ...
(BIAFW)
undefined
undefined%
At close: undefined
0.30
0.30%
Pre-market Jan 06, 2025, 09:52 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -7.94M | -8.15M | -6.33M | -7.27M | -3.31M |
| Depreciation & Amortization | 249.59K | 10.18K | 4.82K | 22.24K | 40.28K |
| Stock-Based Compensation | 748.82K | 248.59K | 43.01K | 275.73K | n/a |
| Other Working Capital | 603.92K | 14.07K | 593.80K | 394.65K | 361.54K |
| Other Non-Cash Items | n/a | 3.71M | -244.35K | 4.28M | 575.11K |
| Deferred Income Tax | n/a | n/a | 3.84M | n/a | n/a |
| Change in Working Capital | 900.79K | 114.20K | 632.82K | 482.62K | 322.01K |
| Operating Cash Flow | -6.04M | -4.07M | -2.05M | -2.21M | -2.49M |
| Capital Expenditures | -22.90K | -219.99K | n/a | -2.89K | -11.40K |
| Acquisitions | -2.19M | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -2.21M | -219.99K | n/a | -2.89K | -11.40K |
| Debt Repayment | -344.98K | 584.16K | 212.26K | 239.20K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 7.73M | 3.11M | 1.48M | 2.33M |
| Financial Cash Flow | -344.98K | 14.34M | 3.33M | 1.72M | 2.33M |
| Net Cash Flow | -8.59M | 10.05M | 1.28M | -495.38K | -166.59K |
| Free Cash Flow | -6.06M | -4.29M | -2.05M | -2.21M | -2.50M |